Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | CORT | AMRX | ||
| Company | Newamsterdam Pharma Company N.V. | Corcept Therapeutics | Amneal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 34.34 | 36.29 | 13.18 | ||
| High | 35.88 | 37.65 | 13.37 | ||
| Low | 34.34 | 35.60 | 13.15 | ||
| Latest | 35.45 | 37.00 | 13.26 | ||
| Change | +1.43 | +1.22 | +0.27 | ||
| % Change | +4.20% | +3.41% | +2.08% | ||
| Volume | 759,700 | 1,851,500 | 1,515,000 | ||
| 20-Day Average Volume | 857,295 | 2,791,335 | 1,783,240 | ||
| Previous Close | 34.02 | 35.78 | 12.99 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.12 | 71.18 | 12.61 | ||
| 20-Day Raw Stochastic | 58.69% | 7.16% | 92.69% | ||
| 20-Day Relative Strength | 49.62 | 24.68 | 66.65 | ||
| Weighted Alpha | +70.84 | -2.13 | +81.86 | ||
| Today's Opinion | 56% Buy | 56% Sell | 100% Buy | ||
| Previous Opinion | 40% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 12/30/25 | -47.29% since 12/30/25 | +2.95% since 12/30/25 | ||
| Low | 32.67 on 01/05/26 | 32.99 on 12/31/25 | 12.33 on 01/05/26 | ||
| High | 35.88 on 01/07/26 | 39.00 on 12/31/25 | 13.37 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | +0.54% since 12/05/25 | -57.03% since 12/05/25 | +8.87% since 12/05/25 | ||
| Low | 32.67 on 01/05/26 | 32.99 on 12/31/25 | 11.83 on 12/08/25 | ||
| High | 37.41 on 12/15/25 | 89.00 on 12/15/25 | 13.37 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +10.06% since 10/07/25 | -59.03% since 10/07/25 | +27.99% since 10/07/25 | ||
| Low | 31.54 on 10/09/25 | 32.99 on 12/31/25 | 9.56 on 10/15/25 | ||
| High | 42.00 on 11/26/25 | 91.00 on 10/08/25 | 13.37 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +82.17% since 07/07/25 | -45.22% since 07/07/25 | +57.67% since 07/07/25 | ||
| Low | 19.28 on 07/08/25 | 32.99 on 12/31/25 | 7.66 on 08/01/25 | ||
| High | 42.00 on 11/26/25 | 91.00 on 10/08/25 | 13.37 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,991,363 | 4,018,182 | 3,979,836 | ||
| Shares Outstanding, K | 113,391 | 105,188 | 314,363 | ||
| Annual Sales | 45,560,000 | 675,040,000 | 2,793,960,000 | ||
| Annual Net Income | -241,600,000 | 141,210,000 | -116,890,000 | ||
| Last Quarter Sales | 350,000 | 207,640,000 | 784,510,000 | ||
| Last Quarter Net Income | -72,010,000 | 19,670,000 | 2,370,000 | ||
| 60-Month Beta | 0.07 | 0.23 | 1.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/05/25 | 0.16 on 11/04/25 | 0.17 on 10/30/25 | ||
| Latest Earnings Date | 02/25/26 | 02/25/26 | 02/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 39.55 | 18.81 | ||